C
Live / Allowed — Notice of allowance issued (as of 17 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 18 Sept 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99400442
- Mark type
- Design + words
- Filed
- 18 Sept 2025
- Published for opposition
- 20 Jan 2026
- Attorney of record
- Christopher Bolinger
Goods and services
- Class 040 — Treatment of materials: Custom manufacture of pharmaceuticals
- Class 042 — Scientific and technological services: Testing, inspection or research of pharmaceuticals, cosmetics or foodstuff
- Class 044 — Medical, beauty and agricultural services: Providing medical information
Owner
- CELLAFA BIOSCIENCE INC., YUSHIMA, BUNKYO-KU, JP
- Astellas Pharma Inc., Tokyo, JP
- Astellas Pharma Inc., Tokyo, JP
Prosecution history
- 01 Apr 2026 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 17 Mar 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 20 Jan 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 20 Jan 2026 — PUBLISHED FOR OPPOSITION
- 14 Jan 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 23 Dec 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 22 Dec 2025 — ASSIGNED TO EXAMINER
- 14 Dec 2025 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 14 Dec 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 18 Sept 2025 — APPLICATION FILING RECEIPT MAILED
- 18 Sept 2025 — NEW APPLICATION ENTERED